Medical specialists from Israel tagged as investigators in clinical trials studying Acute Graft Versus Host Disease

Total 7 results

David Groshar, M.D.
Seen in:
- Petah-Tiqva, BMT unit, Rabin Medical Center, Beilinson Hospital
Trials:
- NCT01596192 (Sub-Investigator)
Conditions:
- Acute Graft Versus Host Disease
Hanna Bernstine, M.D.
Seen in:
- Petah-Tiqva, BMT unit, Rabin Medical Center, Beilinson Hospital
Trials:
- NCT01596192 (Sub-Investigator)
Conditions:
- Acute Graft Versus Host Disease
Inna Rozenfeld, MD
Seen in:
- Zefat, Ziv Medical Center
Trials:
- NCT01706068 (Principal Investigator)
Conditions:
Moshe Yeshurun, M.D.
Seen in:
- Petah-Tiqva, BMT Unit, Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital
- Petah-Tiqva, BMT unit, Rabin Medical Center, Beilinson Hospital
Trials:
- NCT01596192 (Sub-Investigator)
- NCT01555359 (Sub-Investigator)
Conditions:
Polina Stephanski, MD
Seen in:
- Jerusalem, Hadassah Medical Center, Ein Kerem, Jerusalem
Trials:
- NCT02828878 (Principal Investigator)
Conditions:
- Hematological Malignancies
Ron Ram, M.D.
Seen in:
- Petah-Tiqva, BMT Unit, Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital
- Petah-Tiqva, BMT unit, Rabin Medical Center, Beilinson Hospital
Trials:
- NCT01596192 (Principal Investigator)
- NCT01555359 (Principal Investigator)
Conditions:
Tsila Zuckerman, MD
Seen in:
- Haifa, Rambam Health Care Campus
Trials:
- NCT02828878 (Principal Investigator)
Conditions:
- Hematological Malignancies

Clinical Trials on Acute Graft Versus Host Disease

Mesoblast, Inc.
Quintiles, Inc.

Completed

Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD

Grade B Acute Graft Versus Host Disease | Grade C Acute Graft Versus Host Disease | Grade D Acute Graft Versus Host Disease

United States
University of Liege

Terminated

Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD)

Chronic Graft-Versus-Host Disease | Acute Graft-Versus-Host Disease | Steroid Refractory Graft-Versus-Host Disease

Belgium
Jazz Pharmaceuticals

Completed

An Open-Label Study of Defibrotide for the Prevention of Acute Graft-versus-Host-Disease (AGvHD)

Acute-graft-versus-host Disease | Graft-versus-host Disease

United States, Belgium, United Kingdom, Greece, Germany, Spain, France, Italy, Austria, Canada, Bulgaria, Croatia, Poland, Portugal
Jonsson Comprehensive Cancer Center

Withdrawn

Fecal Microbiota Transplantation for the Treatment of Severe Acute Gut Graft-Versus-Host Disease

Acute Graft Versus Host Disease | Gastrointestinal Tract Acute Graft Versus Host Disease | Severe Gastrointestinal Tract Acute Graft Versus Host Disease | Steroid Resistant Gastrointestinal Tract Acute Graft Versus Host Disease

United States
AltruBio Inc.

Completed

Neihulizumab (ALTB-168) in Patients With Steroid-refractory Acute Graft-versus-host Disease or Treatment-refractory Acute Graft-versus-host Disease

Steroid-refractory Acute Graft-versus-Host Disease | Treatment-refractory Acute Graft-versus-Host Disease

United States
Shenzhen Xbiome Biotech Co., Ltd.
Beijing Improve-Quality Tech.Co., Ltd.

Recruiting

Safety and Tolerability of FMT Capsules in Healthy Volunteers

Acute-graft-versus-host Disease

China
Cytopeutics Sdn. Bhd.
Universiti Tunku Abdul Rahman

Active, not recruiting

UCMSCs as Front-line Approach of Treatment for Patients With aGVHD (GVHD Cyto-MSC)

Acute-graft-versus-host Disease

Malaysia
Incyte Corporation

Terminated

Safety and Efficacy of Itacitinib in Combination With Corticosteroids for Treatment of Graft-Versus-Host Disease in Pediatric Subjects

Acute Graft-versus-host Disease

United States, Spain, France, Italy, United Kingdom, Germany
Incyte Corporation

Completed

Safety of Itacitinib in Combination With Corticosteroids for Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Japanese Subjects

Acute Graft-versus-host Disease

Japan
Central Hospital, Nancy, France

Unknown

A Study Comparing Corticosteroids Alone Versus Corticosteroids and Extracorporal Photopheresis (ECP) as First-line Treatment of Standard II Acute Graft-versus-host Disease (PCE-aGVHD)

Acute-graft-versus-host Disease

Medical specialists from Israel tagged as investigators in clinical trials studying Acute Graft Versus Host Disease

Clinical Trials on Acute Graft Versus Host Disease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cyprus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations